Tercero Bocanegra-Hernández G, Cardona-Chavarría JM, Tello-Orduña ER

Language: Spanish
References: 12
Page: 390-396
PDF size: 169.35 Kb.

ABSTRACT

Objetive: Identify alterations in cognitive status in older adults and their association with Diabetes Mellitus in population assigned to UMF 79 of Piedras Negras Coahuila.
Material and Method: Observational, descriptive cross-sectional study, A sample of 378 patients from a universe of 22,801 patients over 60 years of age was considered according to Murray and Larry's formula for sample calculation. History was collected and the Folstein Mini-Mental Test was applied. With the results obtained, the Chi Square formula was applied to demonstrate a significant association and finally the prevalence ratio was applied.
Results: Of the total number of patients identified with altered cognitive status (63), 71% (45) have a history of being diabetic. A significant association was shown [X2(1, N=378) =7.85, p‹.05]. The probability of cognitive alterations is double in older adults with Diabetes according to the prevalence ratio.
Conclusions: An association was found between the presence of Diabetes and alteration in cognitive status. The results coincide with those carried out in other regions. The practice of performing the Mini-Mental test should be considered as part of the approach to diabetic patients.

REFERENCES

1. Sun H, Saeedi P, Karuranga S, PinkepankM, Ogurtsova K, Duncan BB, et al. IDF DiabetesAtlas: Global, regional and country-leveldiabetes prevalence estimates for 2021and projections for 2045. Diabetes Res ClinPract 2022 Jan; 183:109119.

2. Khan MA, Hashim MJ, King J, Govender RD,Mustafa H, Al Kaabi J. Epidemiology of Type2 Diabetes – Global Burden of Disease andForecasted Trends. J Epidemiol GlobHealth. 2020 Mar 10; 10(1).

3. Rojas LS. Deterioro cognitivo moderado yfactores de riesgo. Rev Clin Esc Med. 2019Dec 11;9(5):16-22.

4. González MP, Oltra CJ, Sitges ME, BoneteLB. Revisión y actualización de los criteriosde deterioro cognitivo objetivo y su implicaciónen el deterioro cognitivo leve y la demencia.Rev Neurol. 2021; 72(08):288.

5. Mone P, Gambardella J, Pansini A, de DonatoA, Martinelli G, Boccalone E, et al. Cognitiveimpairment in frail hypertensive elderlypatients: role of hyperglycemia. Cells. 2021;10(8):2115.

6. Damanik J, Yunir E, Type 2 Diabetes Mellitusand Cognitive Impairment Acta Med Indones2021; 53(2):213.

7. Samaras K, Makkar S, Crawford JD, Kochan NA,Wen W, Draper B, et al. Metformin Use Is AssociatedWith Slowed Cognitive Decline and ReducedIncident Dementia in Older Adults With Type2 Diabetes: The Sydney Memory and AgeingStudy. Diabetes Care. 2020 Sep 23;43(11):2691–701.

8. Sluiman AJ, McLachlan S, Forster RB, StrachanMW, Deary IJ, Price JF. Higher baselineinflammatory marker levels predict greatercognitive decline in older people with type2 diabetes: year 10 follow-up of the EdinburghType 2 Diabetes Study. Diabetol.2022 Mar; 65(3):467-76.

9. González HM, Tarraf W, González KA, FornageM, Zeng D, Gallo LC, et al. Diabetes, cognitivedecline, and mild cognitive impairment among diverseHispanics/Latinos: Study of Latinos– Investigationof Neurocognitive Aging Results(HCHS/SOL). Diabetes care. 2020 May1;43(5):1111-7.

10. Bozanic A, Petermann-Rocha F, Waddell H, Parra-Soto S, Cuevas C, Richardson C, et al. Numberof years with type 2 diabetes is associatedwith cognitive impairment in Chilean older adults:A cross-sectional study. Rev Esp Nutr Hum Diet.2021 Sep; 25(3):316-25.

11. Zapata TD, Roque H, Runzer CFM, Parodi JF.Relación entre trastornos neurocognitivos, DiabetesMellitus Tipo 2 y otros factores en adultosmayores del Centro Médico Naval del Perú, entrelos años 2010 a 2015. Rev Neuropsiquiatr.2020 Apr 1; 83(2):87–96.

12. Fonte ST, Santos HDJ. Deterioro cognitivoleve en personas mayores de 85 años. RevCubana Med. 2020 Mar; 59(1).